IP Library › Granted Patent US 11,363,974
Granted Patent B2
US 11,363,974 · App. 16/426,913 · Granted Jun 21, 2022

Method and device for blood glucose level monitoring

Inventors: Jim Rasmusson (Lund, SE); Peter C Karlsson (Lund, SE); Magnus Svensson (Lomma, SE); Claes Nilsson (Lund, SE); Jimmy Eklund (Lund, SE)
Assignee: Sony Group Corporation
A61B5/14532A61B5/4803A61B5/681A61B5/72A61B5/6822A61B5/6824A61B5/6831A61B5/7282
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,363,974
App. No.
16/426,913
Granted
Jun 21, 2022
Kind
B2
Abstract

A method for monitoring a blood glucose level of an individual comprises the steps of receiving (S 1 ) a first glucose value, which has been measured in a body fluid of the individual other than the individual's blood, the first glucose value representing the blood glucose level of the individual with a first delay; receiving (S 6 ) speech of the individual; analyzing (S 7 ) the individual's speech; and determining (S 8 ) a supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the supplementary glucose value is based on the analyzing of the individual's speech.

Claims (24)

1. A method for monitoring a blood glucose level of an individual, comprising the steps of

receiving a first glucose value, which has been measured in a body fluid of the individual other than the individual's blood, the first glucose value representing the blood glucose level of the individual with a first delay;

analyzing the first glucose value to determine whether the represented blood glucose level is acceptable; and

when the represented blood glucose level is determined to be unacceptable, initiating the steps of:

receiving speech of the individual;

analyzing the individual's speech; and

determining a supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the supplementary glucose value is based on the analyzing of the individual's speech.

2. The method of claim 1 , wherein the steps of receiving speech, analyzing the individual's speech and determining the supplementary glucose value are selectively initiated depending on a detected physical activity of the individual.

3. The method of claim 1 , wherein the steps of receiving speech, analyzing the individual's speech and determining the supplementary glucose value are automatically initiated.

4. The method of claim 1 , further comprising creating a prompt to the individual to manually initiate the steps of receiving speech, analyzing the individual's speech and determining the supplementary glucose value.

5. The method of claim 1 , wherein the first glucose value is measured at a first point in time and wherein the steps of receiving speech, analyzing the individual's speech and determining the supplementary glucose value are performed within a predetermined time of the first point in time.

6. The method of claim 1 , further comprising the step of creating an alarm, when the supplementary glucose value indicates that the blood glucose level is below a first predetermined threshold value or above a second predetermined threshold value.

7. The method of claim 1 , comprising the step of reporting the first glucose value to a user at a first frequency when the supplementary glucose value indicates that the blood glucose level is within a first range and reporting the first glucose value to a user at a second frequency when the supplementary glucose value indicates that the blood glucose level is within a second range.

8. The method of claim 1 further comprising the step of determining a current blood glucose level on the basis of both the first glucose value and the supplementary glucose value.

9. The method of claim 8 , wherein the current blood glucose level is based on a weighted combination of the first glucose value and the at least one supplementary glucose value.

10. The method of claim 1 , further comprising the step of monitoring the operation of a sensor used for measuring the first glucose value on the basis of the supplementary glucose value.

11. The method of claim 10 , wherein the monitoring comprises the step of comparing the first glucose value and the supplementary glucose value taking a difference between the first delay and the shorter delay into account.

12. The method of claim 11 , further comprising the step of using a result of the comparing step for calibrating the sensor used for measuring the first glucose value.

13. The method of claim 11 , further comprising the step of using a result of the comparing step for detecting malfunction of the sensor used for measuring the first glucose value.

14. The method of claim 11 , further comprising the step of using a result of the comparing step for determining when the sensor used for measuring the first glucose value is to be replaced.

15. A device for monitoring a blood glucose level of an individual, comprising a first interface for receiving a first glucose value, which has been measured in a body fluid of the individual other than blood, the first glucose value representing the blood glucose level of the individual with a first delay, a second interface for receiving speech from the individual; and control circuitry configured to: analyze the first glucose value to determine whether the represented blood glucose level is acceptable; determine, when the representative blood glucose level is determined to be unacceptable, that a supplementary glucose value needs to be determined; analyze the individual's speech; and determine at least one supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the at least one supplementary glucose value is based on the analyzing of the individual's speech.

16. The device of claim 15 , wherein the device is a wearable configured to be carried by the individual.

17. The device of claim 15 , wherein the device is enabled for connection to a computer network.

18. A system comprising a device for monitoring a blood glucose level of an individual, comprising a first interface for receiving a first glucose value; which has been measured in a body fluid of the individual other than blood, the first glucose value representing the blood glucose level of the individual with a first delay, a second interface for receiving speech from the individual, and control circuitry configured to; analyze the first glucose value to determine whether the represented blood glucose level is acceptable; determine, when the represented blood glucose level is determined to be unacceptable, that a supplementary glucose value need to be determined; analyze the individual's speech; and determine at least one supplementary glucose value, which represents the blood glucose level of the individual with a shorter delay than the first delay; wherein the determination of the at least one supplementary glucose value is based on the analyzing of the individual's speech; and a sensor for measurement of the first glucose value.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2022
From: SONY MOBILE COMMUNICATIONS, INC.
To: SONY CORPORATION
Reel/Frame 059539/0021 →
CHANGE OF NAME Recorded Apr 8, 2022
From: SONY CORPORATION
To: SONY GROUP CORPORATION
Reel/Frame 059633/0115 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2019
From: RASMUSSON, JIM; KARLSSON, PETER C; NILSSON, CLAES; SVENSSON, MAGNUS; EKLUND, JIMMY
To: SONY MOBILE COMMUNICATIONS INC.
Reel/Frame 049327/0161 →
Priority Claims (1)
SE 1850652-7 · May 30, 2018 · national
Continuity (1)
Related Publication 20190365301A1 · Dec 5, 2019